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Infection with Usutu virus (USUV) has been recently as-
sociated with neurologic disorders, such as encephalitis or 
meningoencephalitis, in humans. These findings indicate 
that USUV is a potential health threat. We report an acute 
human infection with USUV in France putatively associated 
with a clinical diagnosis of idiopathic facial paralysis.
Usutu virus (USUV) is a mosquitoborne flavivirus. This virus was detected in South Africa in 1959 and 
is maintained through an enzootic cycle involving birds as 
the main amplifying reservoir hosts and ornithophilic mos-
quito species as vectors (mainly Culex spp.) (1). Mammals, 
including humans, are incidental dead-end hosts. Although 
USUV was considered a tropical or subtropical virus, it was 
recently introduced in central and western Europe. Emer-
gence of USUV in Europe was reported in Austria in 2001, 
but retrospective analyses have suggested an earlier intro-
duction because several epizootics and small outbreaks 
among local birds have been suspected since 1996 (1). In 
2016, a large USUV epizootic was reported in Belgium, 
France, Germany, and the Netherlands (2).
The zoonotic potential of USUV was initially de-
scribed in the Central African Republic and recently 
confirmed in Europe by reports of neuroinvasive in-
fections caused by this virus (1). Further evidence of 
probable human infections was demonstrated by sero-
prevalence studies on healthy blood donor samples: 
prevalence of 1.1% in Italy (3) and 0.02% in Germany 
(4). Furthermore, a recent blood donor screening in Ger-
many identified an acute USUV infection (5). Although 
human infections have not been identified in France, 
deaths of birds during 2015–2016 confirmed USUV 
circulation (6,7).
Moreover, recent data have shown a high prevalence 
(7%) of USUV in Culex pipiens mosquitoes in the Rhone 
River delta, a region also called Camargue, in 2015 (M. 
Eiden et al., unpub. data). Camargue is a landscape of wet-
lands that hosts a diversity of wild bird species, including 
migratory birds, and diverse mosquito populations. This 
environment could potentially favor transmission of USUV 
to humans, similar to that for West Nile virus (WMV) in 
this area (8).
We investigated the zoonotic potential of USUVs and 
WNVs in France by a retrospective flavivirus molecular 
survey of cerebrospinal fluid (CSF) samples collected in 
2016 during the period of maximum mosquito activity 
(May–November). Samples were obtained from patients 
with infectious or neurologic syndromes in 2 towns near 
Camargue. One CSF sample was positive for USUV RNA. 
We report detection of an acute human infection with 
USUV in France associated with an unexpected clinical di-
agnosis of idiopathic facial paralysis.
The Study
We retrospectively screened a collection of RNA extracts 
stored at –80°C by using a modified consensual panflavi-
viruses assay (9) with a One-Step RT-PCR Sybr-Green 
Mixture (QIAGEN, Hilden, Germany). Extracts were ob-
tained from 666 CSF samples collected at the Université 
de Montpellier Hôpital (Montpellier, France) and Nîmes 
University Hospital (Nîmes, France) during May–Novem-
ber 2016. Samples are part of a registered systematic col-
lection established for epidemiologic purposes during the 
surveillance period for risk of infection with arboviruses 
(May–November) in a region of southern France that has 
Aedes albopictus mosquito vectors (Table). RNA extracts 
from samples with a previous probable bacterial or viral 
etiology were not assessed.
One sample showed a positive reverse transcription 
PCR (RT-PCR) result for panflaviruses (cycle threshold 
33). Subsequent Sanger dideoxy sequencing with amplifi-
cation primers for a 260-bp nonstructural protein 5 gene 
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sequence identified a USUV RNA sequence. Phylogenetic 
analysis based on this partial sequence, previously shown 
to accurately discriminate USUV lineages (2,10), identified 
a strain closely related to viruses that were circulating in 
birds in southern Europe (Figure 1).
We tested a remaining stored aliquot of a CSF sam-
ple for USUV by using a specific USUV RT-PCR (cycle 
threshold 30) (11). We inoculated this aliquot onto Vero 
cells and primary human astrocytes (12) after a round of 
amplification in C6/36 cells. Infected Vero cells showed a 
typical cytopathic effect (Figure 2, panel A) (13). We also 
detected infected astrocytes by immunofluorescence, thus 
demonstrating the presence of infectious viral particles 
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Table. Clinical conditions or symptoms associated with microbial 
investigations of cerebrospinal fluid samples for infections with 
arboviruses, France* 
Condition No. (%) positive samples 
Meningitis/encephalitis 277 (41.6) 
Neurologic disorders† 233 (34.9) 
Febrile syndrome 108 (16.2) 
Other 48 (7.0) 
Total 666 (100.0) 
*Samples collected at the Université de Montpellier Hôpital (Montpellier, 
France) and Nîmes University Hospital (Nimes, France) during May–
November 2016. 
†Including (if >2%) convulsion/epileptic seizure (25%); 
paralysis/paresthesia/polyradiculoneuritis/motor loss/palsy (31%); myelitis 
(2%); vascularitis (3%); encephalopathy (6%); Guillain-Barré syndrome 
(4%), headache (15%); and confusion (10%). 
 
Figure 1. Phylogenetic relationship of the France-Montpellier-2016 strain of Usutu virus (USUV) (box; GenBank accession no. 
LT854220), isolated from a 39-year-old man in Montpellier, France, who had an atypical neurologic presentation, compared with 
other USUV strains based on the partial nonstructural protein 5 gene sequence. USUV sequences are shown with their country of 
isolation, year of isolation, and GenBank accession numbers. Hosts from which the strains were detected (bird, mosquito, bat, or 
human) are shown next to strain names. Analysis was processed through the French phylogeny website (http://www.phylogeny.
fr). Nucleotide sequences were aligned by using MUSCLE software (https://www.ebi.ac.uk/Tools/msa/muscle/). The phylogenetic 
tree was constructed by using the maximum-likelihood method in PhyML (http://www.atgc-montpellier.fr/phyml/). One hundred 
bootstrap datasets with random sequence addition were computed to generate a consensus tree drawn with TreeDyn software  
(http://www.treedyn.org/) and rooted with a West Nile virus sequence (GenBank accession no. AF196835). Numbers along branches 
are bootstrap values. Map shows locations where USUV strains were detected in France during 2015–2016. Scale bar indicates 
nucleotide substitutions per site.
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(Figure 2, panel B). However, we detected no viremia in a 
blood sample by specific USUV RT-PCR and no specific 
USUV antibodies. Although virus and antibody dynam-
ics are unknown for acute USUV infection, it is likely that 
these samples, collected 3 days after onset of symptoms, 
were collected too early to detect antibodies, as observed 
for other flaviviruses (14).
The case-patient was a 39-year-old man admitted to 
the Department of Neurology, Université de Montpellier 
Hôpital on November 10, 2016, because of sudden periph-
eral facial palsy and eyelid ptosis after prodromal dysgeu-
sia. We obtained informed consent from the case-patient to 
publish his results.
The patient did not report any previous infectious signs 
or history of recent travel. Symptoms onset occurred 3 days 
before admission, and at the time of admission, he experi-
enced gradual paresthesias of both right limbs and reported 
transient right upper limb palsy for ≈1 h. No other objec-
tive alteration of cranial nerves was detected during neuro-
logic examination. Sensitivity was normal with presence of 
regular osteo-tendinous reflexes. Blood cell count, levels of 
liver enzymes, and renal function results were within ref-
erence ranges. No inflammatory or infectious syndromes 
were observed.
C-reactive protein level in a blood sample was 0.6 
mg/L (reference value <5 mg/L). CSF protein level was 
67 mg/dL (reference range 15–35 mg/dL). There was no 
pleiocytosis. Results of CSF cultures and routine PCRs 
were negative for herpes simplex virus, varicella zoster 
virus, and enteroviruses. Magnetic resonance imaging of 
the brain showed unremarkable results: no ischemic dis-
orders on diffusion-weighted imaging and no enhance-
ment with gadolinium in brainstem and cranial nerves. 
Results of nerve conduction studies on the 4 limbs were 
normal. The patient was given a diagnosis of idiopathic 
facial paralysis.
The patient was given corticoids, valaciclovir, and eye 
drops for prevention of keratitis. He was discharged 3 days 
later, and symptoms of facial palsy disappeared within a 
few weeks.
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Figure 2. Cerebrospinal fluid 
sample of a 39-year-old man 
in Montpellier, France, infected 
with USUV who had an atypical 
neurologic presentation. The 
sample was amplified for 6 days on 
C6/36 cells, and the supernatant 
was used to infect Vero cells or 
primary human astrocytes. A) 
Cytopathic effect (presence of 
adherent dead cells and absence 
of heaps; all dead cells were 
scattered) was observed at day 5 
postinfection of a Vero cell culture. 
Scale bar indicates 100 µm. B) 
Mock or infected primary human 
astrocytes were fixed at day 4 
postinfection and labeled with pan-
flavivirus antibody (MAB10216, 
clone D1–4G2) by indirect 
immunofluorescence (green). 
Strong labeling was observed in 
some cells (arrows). Nuclei are 
labeled with DAPI (4′,6-diamidino-
2-phenylindole) (blue). NI, not 
infected; USUV, Usutu virus. Scale 
bar indicates 10 μm.
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Conclusions
Since the first major epizootic event in 2002, continuous 
geographic expansion of the range of USUV in Europe has 
been shown by reports of epizootics or small outbreaks 
from various countries in western Europe, with widespread 
activity of multiple lineages (2). Thus, USUV has likely 
become a potential human health concern and an increas-
ing number of human infections have been described. Our 
report suggests an acute human USUV infection and shows 
that circulation of USUV involves a wider geographic dis-
tribution in France than reported (2). Phylogenetic analysis 
of the virus sequence isolated from the patient showed a 
strain probably related to the USUV/Spain strain, which 
has been detected in common blackbirds in France (6). 
Because our study region was near Camargue, detection 
of similar strains upstream and at the mouth of the Rhone 
River is consistent.
The zoonotic potential of USUV infection in Europe 
has been reported in a limited number of cases, including 
reports of encephalitis or asymptomatic cases (1). Howev-
er, a retrospective study in a disease-endemic area in Italy 
showed that human USUV infection is not a sporadic event 
and showed a higher incidence than infection with WNV 
(1). For our case-patient, absence of evidence of an infec-
tious syndrome associated with a clinical neuromuscular 
presentation of acute unilateral facial paralysis is atypical. 
However, because idiopathic facial paralysis, also known 
as Bell’s palsy, could be caused by ischemic, immune, and 
infective mechanisms (15) and the well-described neurot-
ropism of some flaviviruses, the etiologic role of USUV 
must not be ruled out.
Our report of an acute human USUV infection in 
France reinforces the need for integrated surveillance in 
animals, vectors, and humans. The atypical clinical pre-
sentation remains an intriguing point that deserves more 
investigations and suggests that human USUV infections 
might display various clinical patterns and could have 
been underestimated.
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